Drug intelligence / Profile preview

loperamide + pink grapefruit juice

Development stage
Discontinued
Modality
Small Molecules
Administration
Oral
01

Overview

Loperamide + pink grapefruit juice refers to the co-administration of loperamide, an over-the-counter antidiarrheal medication, with pink grapefruit juice. Loperamide is a synthetic opioid that acts as a μ-opioid receptor agonist in the gut, slowing intestinal motility and reducing diarrhea. Pink grapefruit juice contains furanocoumarins (notably 6',7'-dihydroxybergamottin) that are potent inhibitors of cytochrome P450 3A4 (CYP3A4) and P-glycoprotein (P-gp), enzymes responsible for metabolizing many drugs including loperamide. When taken together, pink grapefruit juice significantly increases systemic exposure to loperamide by inhibiting its intestinal metabolism and efflux, raising plasma concentrations and increasing the risk of serious adverse effects such as cardiac arrhythmias (including long QT syndrome) and central opioid toxicity[1][2][4][5][6]. This combination is not an approved therapy but has been reported in cases of drug misuse or abuse.

Other names
loperamide with grapefruit juiceloperamide and grapefruit juice
02

Targets

ABCB1 (P-glycoprotein)CYP3A4 (Cytochrome P450 3A4)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on loperamide + pink grapefruit juice.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on loperamide + pink grapefruit juice.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call